77,833 Shares in Docusign Inc. $DOCU Purchased by CapWealth Advisors LLC

Key Points

• CapWealth Advisors LLC has acquired 77,833 shares of Docusign Inc., valued at approximately $6,062,000, indicating growing institutional interest in the company.
• Several analysts have recently upgraded Docusign's stock ratings, with Zacks Research moving it from a "hold" to a "strong-buy" rating, reflecting confidence in the company's performance.
• CFO Blake Jeffrey Grayson sold 6,500 shares of Docusign, representing a 5.80% decrease in his ownership, amid broader insider selling totaling over $7.7 million in the last three months.

CapWealth Advisors LLC bought a new position in Docusign Inc. (NASDAQ:DOCU - Free Report) during the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor bought 77,833 shares of the company's stock, valued at approximately $6,062,000.

Several other hedge funds and other institutional investors have also recently made changes to their positions in the company. Palogic Value Management L.P. lifted its stake in shares of Docusign by 2.2% in the first quarter. Palogic Value Management L.P. now owns 5,438 shares of the company's stock worth $443,000 after buying an additional 117 shares in the last quarter. Wealthspire Advisors LLC lifted its stake in shares of Docusign by 1.9% in the first quarter. Wealthspire Advisors LLC now owns 6,579 shares of the company's stock worth $536,000 after buying an additional 122 shares in the last quarter. Foundry Partners LLC lifted its stake in shares of Docusign by 1.5% in the first quarter. Foundry Partners LLC now owns 8,491 shares of the company's stock worth $691,000 after buying an additional 125 shares in the last quarter. Bessemer Group Inc. lifted its stake in shares of Docusign by 27.5% in the first quarter. Bessemer Group Inc. now owns 602 shares of the company's stock worth $49,000 after buying an additional 130 shares in the last quarter. Finally, Brooklyn Investment Group lifted its stake in shares of Docusign by 24.9% in the first quarter. Brooklyn Investment Group now owns 702 shares of the company's stock worth $57,000 after buying an additional 140 shares in the last quarter. Institutional investors own 77.64% of the company's stock.

Analyst Upgrades and Downgrades

Several research analysts have recently issued reports on the stock. Zacks Research upgraded shares of Docusign from a "hold" rating to a "strong-buy" rating in a research note on Tuesday, September 9th. JMP Securities reissued a "market outperform" rating and set a $124.00 price objective on shares of Docusign in a report on Friday, October 3rd. Royal Bank Of Canada boosted their price objective on shares of Docusign from $90.00 to $95.00 and gave the company a "sector perform" rating in a report on Friday, September 5th. Citigroup boosted their price objective on shares of Docusign from $110.00 to $115.00 and gave the company a "buy" rating in a report on Thursday, September 4th. Finally, UBS Group set a $95.00 price objective on shares of Docusign in a report on Friday, September 5th. One analyst has rated the stock with a Strong Buy rating, four have assigned a Buy rating and fifteen have given a Hold rating to the stock. According to data from MarketBeat, the company currently has a consensus rating of "Hold" and a consensus price target of $94.14.

Insider Activity at Docusign

In related news, CFO Blake Jeffrey Grayson sold 6,500 shares of the business's stock in a transaction that occurred on Wednesday, October 1st. The shares were sold at an average price of $71.20, for a total transaction of $462,800.00. Following the completion of the sale, the chief financial officer directly owned 105,660 shares in the company, valued at approximately $7,522,992. The trade was a 5.80% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, insider Robert Chatwani sold 13,817 shares of the business's stock in a transaction that occurred on Wednesday, September 17th. The shares were sold at an average price of $83.10, for a total transaction of $1,148,192.70. Following the sale, the insider owned 71,162 shares of the company's stock, valued at $5,913,562.20. This trade represents a 16.26% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 102,533 shares of company stock valued at $7,709,933 in the last three months. Corporate insiders own 1.01% of the company's stock.

Docusign Trading Up 1.2%

Shares of NASDAQ DOCU opened at $67.93 on Friday. The firm has a 50 day moving average of $75.02 and a 200 day moving average of $77.97. The firm has a market capitalization of $13.66 billion, a price-to-earnings ratio of 51.08, a price-to-earnings-growth ratio of 3.34 and a beta of 1.02. Docusign Inc. has a 12-month low of $66.35 and a 12-month high of $107.86.

Docusign (NASDAQ:DOCU - Get Free Report) last announced its earnings results on Thursday, September 4th. The company reported $0.92 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.84 by $0.08. The company had revenue of $800.64 million during the quarter, compared to analyst estimates of $780.35 million. Docusign had a net margin of 9.08% and a return on equity of 14.01%. The firm's quarterly revenue was up 8.8% compared to the same quarter last year. During the same period in the previous year, the business posted $0.97 earnings per share. Docusign has set its Q3 2026 guidance at EPS. FY 2026 guidance at EPS. Sell-side analysts predict that Docusign Inc. will post 1.17 EPS for the current year.

Docusign Profile

DocuSign, Inc provides electronic signature solution in the United States and internationally. The company provides e-signature solution that enables sending and signing of agreements on various devices; Contract Lifecycle Management (CLM), which automates workflows across the entire agreement process; Document Generation streamlines the process of generating new, custom agreements; and Gen for Salesforce, which allows sales representatives to automatically generate agreements with a few clicks from within Salesforce.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.